Plasmodium Immunotherapy for Advanced Cancers

Clinical trial NCT03375983 · UNKNOWN

Trial details

NCT number: NCT03375983
Sponsor: CAS Lamvac Biotech Co., Ltd.
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced Cancers

Start date: 2017-11-23
Primary completion: 2023-03-31
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.